CD44 and head and neck squamous cell carcinoma: Linge et al. identified high levels of CD44 mRNA, CD44 protein and SCL3A2 mRNA expression as prognosticators for local recurrence in HNSCC after cisplatin-based postoperative radiochemotherapy (PORT-C).